{"id":1592,"date":"2023-03-02T20:13:05","date_gmt":"2023-03-02T19:13:05","guid":{"rendered":"https:\/\/d3glparxwv1yl3.cloudfront.net\/annualreport\/press-releases\/ipsen-finalise-lacquisition-dalbireo-et-etend-son-portefeuille-en-maladies-rares\/"},"modified":"2023-05-23T14:11:16","modified_gmt":"2023-05-23T14:11:16","slug":"ipsen-finalise-lacquisition-dalbireo-et-etend-son-portefeuille-en-maladies-rares","status":"publish","type":"press_release","link":"https:\/\/www.ipsen.com\/annualreport\/fr\/press-releases\/ipsen-finalise-lacquisition-dalbireo-et-etend-son-portefeuille-en-maladies-rares\/","title":{"rendered":"Ipsen finalise l\u2019acquisition d\u2019Albireo et \u00e9tend son portefeuille en Maladies Rares"},"content":{"rendered":"
Ipsen finalise l\u2019acquisition d\u2019Albireo\u00a0<\/strong>et \u00e9tend son portefeuille en Maladies\u00a0Rares<\/strong><\/p>\n","protected":false},"excerpt":{"rendered":"","protected":false},"author":1,"template":"","categories":[],"tags":[],"class_list":["post-1592","press_release","type-press_release","status-publish","hentry","entry"],"acf":[],"yoast_head":"\n